danust2012 at gmail.com
Mon Sep 5 06:42:17 UTC 2016
On Sep 4, 2016, at 11:04 PM, Keith Henson <hkeithhenson at gmail.com> wrote:
> In its highest dose, the drug was recently shown to annihilate amyloid
> plaques in the brains of a subset of the study’s 165 participants.
> It could cost up to $2.5 billion dollars to test it widely, but the
> investment might be worth the price tag: if it works, aducanumab could
> treat people for Alzheimer’s before they even show symptoms.
This was also reported in Science News. Pretty exciting stuff!
Sample my Kindle books via:
-------------- next part --------------
An HTML attachment was scrubbed...
More information about the extropy-chat